The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions

Background. Thoracic ultrasound is an essential tool in the daily clinical care of pleural effusions and especially parapneumonic pleural effusions (PPEs), in terms of diagnosis, management, and follow-up. Hypoechogenicity index (HI) is a quantitative marker of pleural fluid echogenicity. We aimed t...

Full description

Saved in:
Bibliographic Details
Main Authors: Charalampos Varsamas, Alexandros Kalkanis, Konstantinos I. Gourgoulianis, Foteini Malli
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2020/1283590
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568473450971136
author Charalampos Varsamas
Alexandros Kalkanis
Konstantinos I. Gourgoulianis
Foteini Malli
author_facet Charalampos Varsamas
Alexandros Kalkanis
Konstantinos I. Gourgoulianis
Foteini Malli
author_sort Charalampos Varsamas
collection DOAJ
description Background. Thoracic ultrasound is an essential tool in the daily clinical care of pleural effusions and especially parapneumonic pleural effusions (PPEs), in terms of diagnosis, management, and follow-up. Hypoechogenicity index (HI) is a quantitative marker of pleural fluid echogenicity. We aimed to examine associations of HI with pleural inflammation in patients with PPE. Methods. All patients included underwent a thoracic ultrasound with HI determination at the first day of their admission for a PPE. Thoracentesis was performed in all patients. Demographics, laboratory measurements, and clinical data were collected prospectively and recorded in all subjects. Results. Twenty-four patients with PPE were included in the study. HI was statistically significantly correlated with intensity of inflammation as suggested by pleural fluid LDH (p<0.001, r = −0.831), pleural fluid glucose (p=0.022, r = 0.474), and pleural fluid pH (p<0.001, r = 0.811). HI was correlated with ADA levels (p=0.005, r = −0.552). We observed a statistically significant correlation of HI with pleural fluid total cell number (p<0.001, r = −0.657) and polymorphonuclears percentage (p=0.02, r = −0.590), as well as days to afebrile (p=0.046, r = −0.411), duration of chest tube placement (p<0.001, r = −0.806), and days of hospitalization (p=0.013, r = −0.501). Discussion. HI presents a fast, easily applicable, objective, and quantitative marker of pleural inflammation that reliably reflects the intensity of pleural inflammation and could potentially guide therapeutic management of PPE.
format Article
id doaj-art-03544b0b3ace4994ad6f3a45aa931c75
institution Kabale University
issn 1198-2241
1916-7245
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Canadian Respiratory Journal
spelling doaj-art-03544b0b3ace4994ad6f3a45aa931c752025-02-03T00:58:52ZengWileyCanadian Respiratory Journal1198-22411916-72452020-01-01202010.1155/2020/12835901283590The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural EffusionsCharalampos Varsamas0Alexandros Kalkanis1Konstantinos I. Gourgoulianis2Foteini Malli3Respiratory Medicine Department, University of Thessaly, School of Medicine, Larissa, GreeceLouvain University Center for Sleep and Wake Disorders, Leuven, BelgiumRespiratory Medicine Department, University of Thessaly, School of Medicine, Larissa, GreeceRespiratory Medicine Department, University of Thessaly, School of Medicine, Larissa, GreeceBackground. Thoracic ultrasound is an essential tool in the daily clinical care of pleural effusions and especially parapneumonic pleural effusions (PPEs), in terms of diagnosis, management, and follow-up. Hypoechogenicity index (HI) is a quantitative marker of pleural fluid echogenicity. We aimed to examine associations of HI with pleural inflammation in patients with PPE. Methods. All patients included underwent a thoracic ultrasound with HI determination at the first day of their admission for a PPE. Thoracentesis was performed in all patients. Demographics, laboratory measurements, and clinical data were collected prospectively and recorded in all subjects. Results. Twenty-four patients with PPE were included in the study. HI was statistically significantly correlated with intensity of inflammation as suggested by pleural fluid LDH (p<0.001, r = −0.831), pleural fluid glucose (p=0.022, r = 0.474), and pleural fluid pH (p<0.001, r = 0.811). HI was correlated with ADA levels (p=0.005, r = −0.552). We observed a statistically significant correlation of HI with pleural fluid total cell number (p<0.001, r = −0.657) and polymorphonuclears percentage (p=0.02, r = −0.590), as well as days to afebrile (p=0.046, r = −0.411), duration of chest tube placement (p<0.001, r = −0.806), and days of hospitalization (p=0.013, r = −0.501). Discussion. HI presents a fast, easily applicable, objective, and quantitative marker of pleural inflammation that reliably reflects the intensity of pleural inflammation and could potentially guide therapeutic management of PPE.http://dx.doi.org/10.1155/2020/1283590
spellingShingle Charalampos Varsamas
Alexandros Kalkanis
Konstantinos I. Gourgoulianis
Foteini Malli
The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions
Canadian Respiratory Journal
title The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions
title_full The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions
title_fullStr The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions
title_full_unstemmed The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions
title_short The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions
title_sort use of a novel quantitative marker of echogenicity of pleural fluid in parapneumonic pleural effusions
url http://dx.doi.org/10.1155/2020/1283590
work_keys_str_mv AT charalamposvarsamas theuseofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions
AT alexandroskalkanis theuseofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions
AT konstantinosigourgoulianis theuseofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions
AT foteinimalli theuseofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions
AT charalamposvarsamas useofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions
AT alexandroskalkanis useofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions
AT konstantinosigourgoulianis useofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions
AT foteinimalli useofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions